Global effects of human papillomavirus type 18 E6/E7 in an organotypic keratinocyte culture system

Journal of Virology

Volumn 78, Issue 17, 2004, Pages 9041-9050

  Garner Hamrick, Peggy A ^a   Fostel, J M ^a   Chien, Wei Ming ^b   Banerjee, N Sanjib ^b   Chow, Louise T ^b   Broker, Thomas R ^b   Fisher, Chris ^a,c  

^a PFIZER INC   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c WESTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RETROVIRUS VECTOR; RNA; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DIAGNOSTIC KIT; DNA METABOLISM; DNA MICROARRAY; DNA REPLICATION; DNA SPLICING; E6 GENE; E7 GENE; ENHANCER REGION; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; KERATINOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN CULTURE; ORGANOTYPIC KERATINOCYTE CULTURE SYSTEM; PRIORITY JOURNAL; PROMOTER REGION; RNA METABOLISM; RNA SPLICING; RNA TRANSLATION; VIRUS CELL INTERACTION; VIRUS GENE; WART VIRUS;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; DNA; DNA REPLICATION; DNA-BINDING PROTEINS; G2 PHASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; MITOSIS; MITOTIC SPINDLE APPARATUS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PROTEIN BIOSYNTHESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC;

EID: 4143094867     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.17.9041-9050.2004     Document Type: Article

References (53)

1. Baker, C., and C. Calef. 1997. Maps of papillomavirus mRNA transcripts. In G. Myers, F. Sverdrup, C. Baker, A. McBride, K. Münger, H.-U. Bernard, and J. Meissner (ed.), Human papillomaviruses, compendium, part III. Los Alamos National Laboratory, Los Alamos, N.Mex.
2. Bammert, G. F., and J. M. Fostel. 2000. Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol. Antimicrob. Agents Chemother. 44:1255-1265.
3. Banks, L., C. Edmonds, and K. H. Vousden. 1990. Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells. Oncogene 5:1583-1389.
4. Barnard, P., and N. A. McMillan. 1999 The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-α. Virology 259:305-313.
5. Barnard, P., E. Payne, and N. A. McMillan. 2000. The human papillomavirus E7 protein is able to inhibit the antiviral and anti-growth functions of interferon-α. Virology 277:411-419.
6. Chang, Y. E., and L. A. Laimins. 2000. Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31. J. Virol. 74:4174-4182.
7. Cheng, S., D. C. Sctmidt-Grimminger, T. Murant, T. R. Broker, and L. T. Chow. 1995. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev. 9:2335-2349.
8. Chien, W.-M., J. N. Parker, D.-C. Schmidt-Grimminger, T. R. Broker, and L. T. Chow. 2000. Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entry. Cell Growth Diff. 11:425-435.
9. Chien, W.-M., F. Noya, H. M. Benedict-Hamilton, T. R. Broker, and L. T. Chow. 2002. Alternative fates of keratinocytes transduced by human papillomavirus type 18 E7 during squamous differentiation. J. Virol. 76:2964-2972.
10. Chow, L. T., and T. R. Broker. 1997. Small DNA tumor viruses, p. 267-302. In N. Nathanson (ed.), Viral pathogenesis. Lippincott-Raven Publishers, Philadelphia, Pa.
11. Chow, L. T., and T. R. Broker. 1997. In vitro experimental systems for HPV: Epithelial raft cultures for investigations of viral reproduction and pathogenesis and for genetic analyses of viral proteins and regulatory sequences. Clin. Dermatol. 15:217-227.
12. Demers, G. W., E. Espling, J. B. Harry, B. G. Etscheid, and D. A. Galloway. 1996. Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation. J. Virol. 70:6862-6869.
13. Dollard, S. C., J. L. Wilson, L. M. Demeter, W. Bonnez, R. C. Reichman, T. R. Broker, and L. T. Chow. 1992. Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. Genes Dev. 6:1131-1142.
14. Duensing, S., A. Duensing, E. R. Flores, A. Do, P. F. Lambert, and K. Mhnger. 2001. Centrosome abnormalities and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytes. J. Virol. 75:7712-7716.
15. Duensing, S., A. Duensing, C. P. Crum, and K. Mhnger. 2001. Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype. Cancer Res. 61:2356-2360.
16. Duensing, A., J. Basile, S. Piboonniyom, S. Gonzalez, C. P. Crum, and K. Mhnger. 2000. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc. Natl. Acad. Sci. USA 97:10002-10007.
17. Duffy, C. L., S. L. Phillips, and A. J. Klingelhutz. 2003. Microarray analysis identifies differentiation-associated genes regulated by human papillomavirus type 16 E6. Virology 314:196-205.
18. Fisher, C. 1994. The cellular basis of development and differentiation in mammalian keratinizing epithelia, p. 131-150. In I. Leigh, B. Lane, and F, Watt (ed.), The keratinocyte handbook. Cambridge University Press, Cambridge, England.
19. Fisk, H. A., and M. Winey. 2001. The mouse Mps1p-like kinase regulates centrosome duplication. Cell 106:95-104.
20. Flores, E. R., B. L. Allen-Hoffmann, D. Lee, and P. F. Lambert. 2000. The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle. J. Virol. 74:6622-6631.
21. Frattini, M. G., H. B. Lim, J. Doorbar, and L. A. Laimins. 1997. Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates. J. Virol. 71:7068-7072.
22. Garner-Hamrick, P., and C. Fisher. 2002. HPV episomal copy number closely correlates with cell size in keratinocyte monolayers. Virology 301:334-341.
23. He, W., and C. Fisher. 2003. Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7. J. Virol. 77:10566-10577.
24. Howley, P. M. 1996. Papillomavirinae: the viruses and their replication, p. 2045-2076. In B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
25. Jewers, R. J., P. Hildebrandt, J. W. Ludlow, B. Kelt, and D. J. McCance. 1992. Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes. J. Virol. 66:1329-1335.
26. Jian, Y. C., D.-C. Schmidt-Grimminger, W.-M. Chien, X. Wu, T. R. Broker, and L. T. Chow. 1998. Post-transcriptional induction of p21cip1 protein by human papillomavirus E7 inhibits unscheduled DNA synthesis reactivated in differentiated keratinocytes. Oncogene 17:2027-2038.
27. Jian, Y., B. A. Van Tine, W.-M. Chien, G. M. Shaw, T. R. Broker, and L. T. Chow. 1999. Concordant induction of cyclin E and p21cip1 in differentiated keratinocytes by the HPV E7 protein inhibits cellular and viral DNA synthesis. Cell Growth Differ. 10:101-111.
28. Jones, D. L., R. M. Alani, and K. Münger. 1997. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cipl-mediated inhibition of cdk2. Genes Dev. 11:2101-2111.
29. Klingelhutz, A. J., S. A. Foster, and J. K. McDougall. 1996. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380:79-82.
30. Kuo, S.-R., J.-S. Liu, T. R. Broker, and L. T. Chow. 1994. Cell-free replication of the human papillomavirus DNA with homologous viral E1 and E2 proteins and human cell extracts. J. Biol. Chem. 269:24058-24065.
31. Liu, Y., J. J. Chen, Q. Gao, S. Dalal, Y. Hong, C. P. Mansur, V. Band, and E. J. Androphy. 1999. Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells. J. Virol. 73:7297-7307.
32. Meyers, C., M. G. Frattini, J. B. Hudson, and L. A. Laimins. 1992. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257:971-973.
33. McIntyre, M. C., M. G. Frattini, S. R. Grossman, and L. A. Laimins. 1993. Human papillomavirus type 18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding. J. Virol. 67:3142-3150.
34. Münger, K., and A. L. Halpern. 1997. HPV 16 E7: Primary structure and biological properties, p. 17-36. In G. Myers, F. Sverdrup, C. Baker, A. McBride, K. Münger, H.-U. Bernard, and J. Meissner, (ed.), Human papillomaviruses compendium, part III. Los Alamos National Laboratory, Los Alamos, N.Mex.
35. Nees, M., J. M. Geoghegan, T. Hyman, S. Frank, L. Miller, and C. D. Woodworth. 2001. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes. J. Virol. 75:4283-4296.
36. Norman, T. C., D. L. Smith, P. K. Sorger, B. L. Drees, S. M. O'Rourke, T. R. Hughes, C. J. Roberts, S. H. Friend, S. Fields, and A. W. Murray. 1999. Genetic selection of peptide inhibitors of biological pathways. Science 285:591-595.
37. Noya, F., W.-M. Chien, T. R. Broker, and L. T. Chow. 2001. p21cip1 degradation in differentiated keratinocytes is abrogated by costabilization with cyclin E induced by human papillomavirus E7. J. Virol. 75:6121-6134.
38. Noya, F., W.-M., Chien, X. Wu, N. S. Banerjee, J. C. Kappes, T. R. Broker, and L. T. Chow. 2002. The promoter of the human proliferating cell nuclear antigen gene is not sufficient for cell cycle-dependent regulation in organotypic cultures of keratinocytes. J. Biol. Chem. 277:17271-17280.
39. Park, R. B., and E. J. Androphy. 2002. Genetic analysis of high-risk E6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes. J. Virol. 76:11359-11364.
40. Parker, J. N., W. Zhao, K. J. Askins, T. R. Broker, and L. T. Chow. 1997. Mutational analyses of differentiation-dependent human papillomavirus type-18 enhancer elements in epithelial raft cultures of neonatal foreskin keratinocytes. Cell Growth Differ. 11:751-762.
41. Patel, D., S. M. Huang, L. A. Baglia, and D. J. McCance. 1999. The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J. 18:5061-5072.
42. Ruutu, M., P. Peitsaro, B. Johansson, and S. Syrjänen. 2002. Transcriptional profiling of a human papillomavirus 33-positive squamous epithelia cell line which acquired a selective growth advantage after viral integration. Int. J. Cancer 100:318-326.
43. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
44. Schwarze, S. R., S. E. DePrimo, L. M. Grabert, V. X. Fu, J. D. Brooks, and D. Jarrod. 2002. Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells. J. Biol. Chem. 277:14877-14883.
45. Shamji, A. F., P. Nghiem, and S. L. Schreiber. 2003. Integration of growth factor and nutrient signaling: implications for cancer biology. Mol. Cell 12:271-280.
46. Thomas, G. 2000. An encore for ribosome biogenesis in the control of cell proliferation, Nat. Cell Biol. 2:E71-E72.
47. Thomas, J. T., W. G. Hubert, M. N. Ruesch, and L. A. Laimins. 1999. Hum. papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc. Natl. Acad. Sci. USA 96:8449-8454.
48. Thomas, J. T., S. T. Oh, S. S. Terhune, and L. A. Laimins. 2001. Cellular changes induced by low-risk human papillomavirus type 11 in keratinocytes that stably maintain viral episomes. J. Virol. 75:7564-7571.
49. Veldman, T., I. Horikawa, J. C. Barrett, and R. Schlegel. 2001. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J. Virol. 75:4467-4472.
50. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Muoz. 1999. Hum. papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
51. Wells, S. I., B. J. Arinow, T. M. Wise, S. S. Williams, J. A. Couget, and P. M. Howley. 2003. Transcriptome signature of irreversible senescence in human-papillomavirus-positive cervical cancer cells. Proc. Natl. Acad. Sci. USA 100:7093-7098.
52. Wilson, J. L., Dollard, S. C., Chow, L. T., and T. R. Broker. 1992. Epithelial-specific gene expression during differentiation of stratified primary human keratinocyte cultures. Cell Growth Differ. 3:471-183.
53. zur Hausen, H. 1999. Viruses in human cancers. Eur. J. Cancer 35:1878-1885.